Iloprost Power Disc-15 in Pulmonary Arterial Hypertension
Status:
Terminated
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
A Phase IIIb, Multicenter, Open-Label Study of Patients With Pulmonary Arterial Hypertension
Treated With Iloprost(Inhalation)Evaluating Safety and Inhalation Times When Converting From
Power Disc-6 to Power Disc-15 With the I-neb® Adaptive Aerosol Delivery® System (I-neb® AAD®)